The Journal of Clinical Endocrinology & Metabolism · 2012 · 250 citations · 34 references
MedicineChronic Disease PreventionDietary AssessmentHuman NutritionNutritional EpidemiologyDiabetes MellitusMetabolic SyndromeVitamin DVitamin D MetabolismFamily Health HistoryMetabolic Syndrome EpidemiologyMetabolic Syndrome Risk AssessmentSerum 25-Hydroxyvitamin D Status
CONTEXT: Serum 25-hydroxyvitamin D [25(OH)D] concentration has been inversely associated with the prevalence of metabolic syndrome (MetS), but the relationship between 25(OH)D and incident MetS remains unclear. OBJECTIVE: We evaluated the prospective association between 25(OH)D, MetS, and its components in a large population-based cohort of adults aged 25 yr or older. DESIGN: We used baseline (1999-2000) and 5-yr follow-up data of the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). PARTICIPANTS: Of the 11,247 adults evaluated at baseline, 6,537 returned for follow-up. We studied those without MetS at baseline and with complete data (n = 4164; mean age 50 yr; 58% women; 92% Europids). OUTCOME MEASURES: We report the associations between baseline 25(OH)D and 5-yr MetS incidence and its components, adjusted for age, sex, ethnicity, season, latitude, smoking, family history of type 2 diabetes, physical activity, education, kidney function, waist circumference (WC), and baseline MetS components. RESULTS: A total of 528 incident cases (12.7%) of MetS developed over 5 yr. Compared with those in the highest quintile of 25(OH)D (≥34 ng/ml), MetS risk was significantly higher in people with 25(OH)D in the first (<18 ng/ml) and second (18-23 ng/ml) quintiles; odds ratio (95% confidence interval) = 1.41 (1.02-1.95) and 1.74 (1.28-2.37), respectively. Serum 25(OH)D was inversely associated with 5-yr WC (P < 0.001), triglycerides (P < 0.01), fasting glucose (P < 0.01), and homeostasis model assessment for insulin resistance (P < 0.001) but not with 2-h plasma glucose (P = 0.29), high-density lipoprotein cholesterol (P = 0.70), or blood pressure (P = 0.46). CONCLUSIONS: In Australian adults, lower 25(OH)D concentrations were associated with increased MetS risk and higher WC, serum triglyceride, fasting glucose, and insulin resistance at 5 yr. Vitamin D supplementation studies are required to establish whether the link between vitamin D deficiency and MetS is causal.
34
Harmonizing the Metabolic Syndrome
K. G. M. M. Alberti, Robert H. Eckel, Scott M. Grundy et al. · Circulation · 2009 · 14.7K citations · Full text
Michael F. Holick, Neil Binkley, Heike A. Bischoff‐Ferrari et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 10.5K citations · Full text
Medicine, Endocrinology, Nutrition +17
A. Catharine Ross, JoAnn E. Manson, Steven A. Abrams et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 4K citations · Full text
Decreased bioavailability of vitamin D in obesity
Jacobo Wortsman, Lois Y. Matsuoka, Tai C. Chen et al. · American Journal of Clinical Nutrition · 2000 · 3.2K citations · Full text
Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults
Earl S. Ford, Umed A. Ajani, Lisa C. McGuire et al. · Diabetes Care · 2005 · 665 citations · Full text